title: Comparative safety of therapies in systemic lupus erythematosus.
abstract: Systemic lupus erythematosus (SLE) is the prototypic autoimmune disease with diverse clinical manifestations, affecting virtually all organ systems. A wide variety of medications are used for treatment, depending on organ involvement and severity. This article summarizes the adverse effects associated with different drugs currently used to treat SLE.
authors.affiliation: Division of Rheumatology and Allergy-Clinical Immunology, North Shore-Long Island Jewish Health System, Lake Success, NY 11042, USA. jmosak@nshs.edu
authors.forename: Joseph
authors.initials: J
authors.lastname: Mosak
authors.forename: Richard
authors.initials: R
authors.lastname: Furie
mesh_terms: D000962:Antimalarials / Q000008:administration & dosage / Q000009:adverse effects*; D003603:Cytotoxins / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*
chemical_list: D000962:Antimalarials; D003603:Cytotoxins; D007166:Immunosuppressive Agents